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CC BY-NC-ND license (http://creativeAbstract It is well known that with increasing age, the risk of acquiring certain age-related
diseases e such as diabetes, cancer, cardiovascular disease and neurodegenerative diseases,
increases. Several theories have been proposed to explain the reason why ageing leads to high-
er susceptibility to disease. Over time, many of these theories have been proven wrong.
Currently, the two theories holding the interest of researchers in this field are the oxidative
damage theory and hyperfunction theory of ageing. The former is an old theory which explains
that ageing is as a result of oxidative damage (to macromolecular components of the cell) by
reactive oxygen species produced as a normal part of metabolism. The hyperfunction theory is
a much newer theory which explains that ageing is as a result of the unnecessary and unwanted
continuation of certain metabolic processes at old age. In this review, we discuss the mecha-
nisms which underlie the development of age-related cancer. We also discuss the aforemen-
tioned theories of ageing. We conclude by explaining the opposing views of proponents of
both theories and provide a new viewpoint by revealing a point of synergy in the two theories.
Copyright ª 2016, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
With increasing age, the body tends to accumulate damage
and the functions of different organs begin to decline.
Ageing has been shown to correlate with the onset of many
terminal diseases such as: cardiovascular disease, type II
diabetes, neurodegenerative diseases such as Huntington’s
disease and Alzheimer’s disease and cancer.1 Ageing can
thus be said to be a major risk factor for these diseases.
Several hundred theories of ageing have been put forward
by researchers in the past, with nearly all of them being
disproved with time. Currently, there are two highly
prominent theories of ageing generating the interest ofity of Chongqing Medical
16.04.002
ng Medical University. Production
commons.org/licenses/by-nc-nd/biogerontologists: the oxidative damage theory and the
hyperfunction theory.2
Theories of ageing and mechanisms by which
ageing leads to age-related disease.
The oxidative damage theory of ageing
From the oxidative damage point of view, ageing occurs as
a result of the accumulation of molecular damage caused
by reactive oxygen species (ROS) which are normally pro-
duced as a by-product of metabolism.3,4 ROS are capable of
damaging cellular constituents including proteins, lipids
and DNA (where they cause double strand breaks and
oxidative lesions). This damage then triggers the activity ofand hosting by Elsevier B.V. This is an open access article under the
4.0/).
106 Perspectivescellular machinery involved in damage repair. Genes that
code for proteins involved in rectifying damage to DNA are
known as tumour suppressor genes. The tumour suppressors
can be classified into two types based on their mode of
action: caretaker tumour suppressors and gatekeeper
tumour suppressors.
Caretaker tumour suppressors and cancer
Caretaker tumour suppressors are the first line of defence
against DNA damage. They help to prevent DNA damage in
the first place. Caretaker tumour suppressors also help to
repair DNA in the event of damage. They can help in
nucleotide-excision repair, mismatch repair, base-excision
repair, as well as repairing double strand breaks.4
Caretaker tumour suppressors involved in preventing
DNA damage by ROS, include antioxidant enzymes such as
superoxide dismutase (SOD), catalase and glutathione
peroxidase. These enzymes are responsible for clearing up
free radicals before they cause damage to the body.4
The mitochondrial electron transport chain (ETC) is not
100% efficient in transferring electrons and an electron
sometimes ‘leaks out’ as it is being transferred from one
component of the ETC to another. This electron can acci-
dentally be picked up by oxygen, forming superoxide (a
very pertinent example of ROS).5 In the process, ROS-
induced oxidative damage to the genes encoding care-
taker tumour suppressor proteins, leads to an insufficient
amount of functional proteins that can act to prevent DNA
damage as well as repair it whenever it occurs. Hence,
more DNA damage occurs and this accumulates as one gets
older. This may explain the increased risk of diseases in the
elderly, such as cancer- as a result of mutation accumula-
tion. Evidence is accumulating that shows that oxidative
stress can cause DNA damage and mutations which lead to
cancer in mice6 also, protection from ROS has been shown
to increase healthspan.7
Gatekeeper tumour suppressors and cancer
Gatekeeper tumour suppressors are responsible for clearing
up cells that are prone to be neoplastic, i.e., cells in which
the DNA has already undergone such extensive damage or
mutation that it will be difficult to repair. An example of a
gatekeeper tumour suppressor is p53. Gatekeeper tumour
suppressors usually ‘clear up’ these cells by causing them to
senesce or undergo apoptosis.8
Although this mechanism sounds good for tumour sup-
pression and cancer prevention, it can have terrible con-
sequences for ageing and longevity. This is due to the fact
that when cells undergo senescence, they secrete certain
substances such as growth factors and degradative enzymes
including matrix metalloproteinases which affect their im-
mediate surroundings. Thus as one ages, the environment
around senescent cells becomes a fertile place for the
development of pre-cancerous cells (cells which have un-
dergone sufficient mutations) that have accumulated
throughout the person’s life and this is what leads to cancer
as one increases in age.8 This is a vivid example of the
concept of antagonistic pleiotropy e a term used to
describe the phenomenon in which the same genes that
control ‘good’ phenotypes (such as senescence/cancer
prevention) at young age, become responsible forprovoking ‘detrimental’ phenotypes (such as tumour for-
mation) in old age.9
Also, apoptosis has been linked to ageing because in
adult humans, many of our cells are mitotic (capable of
dividing) while some are post-mitotic. Thus if when the DNA
in our cells undergoes extensive mutation, the cell’s
response is to cause apoptosis right away, then as a person
gets older, the number of cells capable of regeneration, as
well as non-renewable tissues of irreplaceable post-mitotic
cells, gets depleted and this leads to ageing (as a person
runs out of stem cells and irreplaceable cells) and subse-
quent diseases.8
The hyperfunction theory of ageing
From the hyperfunction point of view, ageing results as a
quasi-programmed hyperfunction from youth. This means
that processes contributing to growth and reproduction
during development, continue to occur in later life (post-
development) excessively and unwantedly, eventually giv-
ing rise to hypertrophy, hyperplasia as well as subsequent
age-related diseases such as cancer and neurodegenerative
diseases.10,11
The originator of the hyperfunction theory (M.V. Bla-
gosklonny) argues that ageing originates as a result of hy-
perfunction and not molecular damage.11 He argues that
the hyperfunction of the TOR (target of rapamycin)
pathway (a nutrient sensing pathway) is what gives rise to
ageing and subsequently, diseases of ageing.
The pieces of evidence he used to draw this inference
interestingly, are previously published data which were
interpreted using older theories of ageing especially the
oxidative damage theory and the trade-off theory. The
conclusions of researchers using these theories were never
really a hundred percent convincing; because there were
still some observations that these theories could not
explain; for instance ‘why does dietary restriction increase
lifespan and decrease reproductive ability’? The reason why
this was a troubling question is because, from the point of
view of the evolutionary theory, organisms survive in order
to be able to reproduce; thus if they encounter something
that could limit their life (e.g. starvation), the organism
will likely adapt to it in a way that favours reproduction
(even at the expense of their own lifespan). In the case of
limited food, the organism may adapt by channelling nearly
all the nutrients it gets into reproduction, while leaving just
a sufficient amount to activate longevity mechanisms (such
as somatic maintenance) in order to live long enough to
reach the end of the reproductive period. This is known as
the ‘trade-off’ theory.2
The paradox in the trade-off theory is that, if the trade-
off theory were true, then dietary restriction ought to
shorten lifespan, since most of the nutrients will be chan-
nelled away from somatic maintenance towards reproduc-
tion, but recent observations have shown that dietary
restriction actually increases lifespan and decreases
reproductive ability. It also postpones the onset of age-
related diseases.10,12
From the evolutionary point of view, reproductive ability
is more likely to be favoured compared to fitness/lifespan
because in the wild, animals mostly die of external factors
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for an organism to develop and then reproduce as quickly as
possible before external factors kill the organism, and
natural selection may have adapted animals for this; even
though there seems to be pieces of evidence that conflict
with this line of thought.2
One of the interesting paradoxes in the oxidative dam-
age theory was created by recent experiments which
showed that the lifespan of certain organisms (such as
Yeast and Caenorhabditis elegans) is lengthened even in
the presence of increased ROS.10 This observation obviously
contradicts the oxidative damage theory, although scien-
tists explained that the increased lifespan was as a result of
an increased stress resistance; a phenomenon known as
hormesis.10
Other experiments have brought about mixed results-
while some have shown that antioxidants (which ought to
combat ROS and therefore increase lifespan) shortened the
lifespan of worms, others have shown that antioxidants
increased worm lifespan.3 At present, the conclusion is that
there is no convincing correlation between lifespan and
levels of ROS.10
Contradictions like this inspired Blagosklonny to put
forward a new theory e the theory of hyperfunction. In this
theory, the unnecessary stimulation of the TOR pathway
post-development, gives rise to the accumulation of un-
needed proteins as well as unnecessary growth. Since the
TOR pathway inhibits autophagy, these unwanted proteins
accumulate because they are not being degraded. The TOR
pathway also inhibits apoptosis, so the cell does not die; it
just keeps growing.10,12 Importantly, Blagosklonny noted
that, in the event that the DNA acquires a mutation that
inhibits the cell from dividing, then the cell enters into a
senescent ‘hyperfunctional’ state in which it just keeps
growing and growing actively, without dividing and without
undergoing apoptosis.12 Also, these senescent cells tend to
secrete proteins (such as growth factors and matrix met-
alloproteinases) that induce the growth of other cells in
their environment and worse still, degrade the stroma,
thereby creating an environment that enables pre-
malignant cells (epithelial cells with oncogenic mutations)
to thrive and become malignant. This is what gives rise to
cancer in old individuals.
In summary, Blagosklonny12 proposes that as a person
gets older, the TOR pathway becomes hyperactive-since its
effects are only needed in small amounts once develop-
ment is completed; but because an adaptation for switch-
ing off or downregulating the TOR pathway post
developmentally has not evolved yet, the products (pro-
teins) of the TOR pathway accumulate in the cell, and if a
mutation causes that cell to be arrested from dividing, then
the cell becomes senescent and hyperfunctional e using its
secretory phenotype to make its environment suitable for
the development of cancer.12
There is evidence to show that mTOR is indeed involved
in organismal ageing; and an increasing number of studies
have demonstrated that rapamycin (an inhibitor of mTOR)
extends lifespan in mice and prevents age-related pathol-
ogies including cancer.13,14 Rapamycin has also been shown
to slow ageing and improve the health of obese mice.13 New
evidence has also come up that shows that Rapamycinsuppresses geroconversion, maintaining quiescence instead
of senescence.15
According to Blagosklonny, the hyperfunction theory
explains why dietary restriction increases lifespan and
postpones the development of age-related diseases
(because ingesting a lower amount of nutrients e e.g. when
undergoing dietary restriction- leads to a lower amount of
TOR activity, thus unnecessary proteins do not accumulate
any longer, since these proteins are no longer made in
excessive amounts and can now be degraded through
autophagy).10 He also proposes that the protein accumu-
lation that arises due to hyperactive TOR signalling causes
protein aggregation diseases such as Huntington’s disease.
In the opinion of the authors of the present paper, both
the oxidative damage theory and the hyperfunction theory
are plausible. In fact, they should be integrated to form one
theory, because they are not mutually exclusive. For
instance, the hyperfunction theory cannot be explained
without mentioning molecular damage (even though Bla-
gosklonny argues that ageing is as a result of cellular
damage and not molecular damage). Also, the oxidative
damage theory does not have logical explanations for some
of the observations that have been observed experimen-
tally, therefore it needs to encompass the hyperfunction
theory (see Fig. 1).
A synergy between the hyperfunction and
oxidative damage theories of ageing
The hyperfunction theory is impossible to explain without
incorporating molecular damage; the oxidative damage
theory is only logical if it includes the concept of
hyperfunction!
The point we are making here is that the process by
which hyperfunction of the TOR pathway gives rise to age-
related diseases (using cancer as a case study) actually
involves molecular damage! According to Blagosklonny, for
a cell to become senescent, it has to be arrested from the
cell cycle.12 This arrest is usually due to mutations in the
DNA that are beyond what the DNA repair enzymes can
repair, hence gatekeepers (including checkpoint proteins)
arrest the cell and stop it from dividing. Thus the cell
continues to grow, but cannot divide. The cell also begins to
secrete proteins that make the environment suitable for
pre-cancerous cells to grow and become cancers (Note
that these ‘pre-cancerous’ cells are so-called, because they
have acquired a number of DNA mutations and are thus
prone to develop into cancer cells). From this explanation,
it is obvious that DNA mutations are critical to explaining
the hyperfunction theory, and this is what the molecular
damage theory is all about.
As for the oxidative damage theory, it obviously has to
include the hyperfunction theory, in order to be sound. ROS
causes damage to cell components such as proteins, lipids
and DNA. Damage to DNA can cause the cell cycle to be
arrested and this leads to senescence since the cell can no
longer divide; but then a closer look at the senescent
phenotype, reveals that the cell is hyperfunctional e it is
actively undergoing metabolism, it is growing, it does not
undergo apoptosis and most of all, it has a very important
secretory phenotype8 and this can all be traced to
Fig. 1 The relationship between ROS, TOR, ageing and disease. Cells are arrested from participating in cell division when there is
extensive DNA damage. This DNA damage can be caused by a variety of factors including but not limited to reactive oxygen species
(ROS), telomere erosion, mutation and environmental factors. Cell cycle arrest can trigger apoptosis or senescence under different
conditions. Senescence is characterised by hypertrophy, hyperplasia and creation of an environment suitable for pre-cancerous
cells to thrive, due to the secretion of matrix metalloproteinases (MMPs) and growth factors. This leads to cancer as ageing
proceeds. mTOR has been implicated in the ageing process. Its mechanism of action includes: aiding senescence and inhibiting
apoptosis. Rapamycin administration and dietary restriction have both been shown to slow down ageing and disease progression as
they both act to inhibit mTOR.
108 Perspectiveshyperactivity of the TOR pathway (because dietary re-
striction reduces TOR activity and therefore dramatically
reduces cellular hyperfunction which has been implicated
in accelerating the ageing process and the development of
ageing-related diseases).12 Thus, we conclude by re-
affirming our point: the hyperfunction theory is incom-
plete without molecular damage, and the oxidative damage
theory is not sound without mentioning the obvious hy-
perfunction of ageing cells!
Conclusion
In conclusion, we believe that the TOR pathway becomes
hyperfunctional after the growth and development stages
of life and this can lead to ageing and subsequently, ageing-
related diseases. It is also true that as a human being ad-
vances in age, the body accumulates damage of all sorts
(molecular as well as cellular), and these eventually lead to
organ failure and subsequent diseases. Thus anyintervention that can slow down the onset of this damage-
hyperfunction phenotype is most likely going to slow down
the onset of ageing-related diseases as well. Only further
laboratory experiments with model organisms and clinical
trials with humans will be able to reveal the complex
mechanism(s) of ageing and how ageing leads to the
development of age-related diseases.References
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